Latest News and Press Releases

The biotechnology space is delivering market-moving developments, as companies across oncology, neuroscience, gene therapy, medical devices, and more

NeOnc(NASDAQ: NTHI) is rapidly emerging as a development-stage neuro-oncology innovator

our names that have emerged as closely watched stories spanning biotechnology, AI, aerospace, communications, and digital infrastructure

NeOnc Technologies Holdings (NASDAQ: NTHI) continues to build momentum as a neuro-oncology sector trailblazer

Multiple clinical-stage companies are delivered meaningful regulatory, clinical, and corporate milestones.

Volume often tells investors where attention is flowing. $NTHI, $AKAN, $NOK, $DSY

The race to develop more effective treatments for some of the deadliest forms of cancer is quietly unfolding across biotechnology

Yet one of oncology's greatest challenges, Glioblastoma, remains largely unsolved.

Eli Lilly's (NYSE:LLY) strong Phase 3 results for Retevmo places the oncology community in the spotlight

NeOnc (NASDAQ:NTHI) is developing therapies and delivery technologies targeting aggressive brain cancers and CNS-related conditions, and could be part of t